Skip to Content

Cancer Research & Clinical Trials

The cancer team at Adventist HealthCare recognizes the important role that clinical trials play in the study of new, innovative treatments or strategies that may lead to prevention, earlier detection, better treatments or cures for conditions such as cancer. Our expert cancer research team includes physicians and clinical research nurses as well as research associates and assistants who are involved with more than 65 cancer studies each year.

Search or Browse Cancer Clinical Trials

Showing 1-10 of 34

Sorted By:

  • ARCTIC

    Randomised, open label, multi-centre study assessing the efficacy and safety of MEDI4736 versus Standard of Care in NSCLC patients with PD-L1 positive tumours.

  • ARROW

    Study compares once-weekly carfilzomib dosing in combination with dexamethasone to twice-weekly carfilzomib dosing in combination with dexamethasone.

  • BAX69391401

    Study evaluates the safety and tolerability of BAX69 in combination with 5-fluorouracil (5-FU)/leucovorin (LV) or panitumumab to determine the recommended phase II dose (RP2D) of each combination.

  • Doxorubicin Hydrochloride/Cyclophosphamide

    Study of how doxorubicin hydrochloride and cyclophosphamide followed by paclitaxel work in treating patients with triple negative breast cancer.

  • ERA 223

    Study to determine if the addition of radium-223 dichloride to standard treatment is able to prolong life and to delay events specific for prostate cancer.

  • GAMMA-1

    Study to compare the efficacy of andecaliximab (formerly GS-5745) versus placebo as measured by overall survival.

  • IMbassador250

    Study evaluates the safety and efficacy of atezolizumab in combination with enzalutamide compared with enzalutamide alone in participants with mCRPC.

  • IMpower 131

    Randomized, open-label study to evaluate the safety and efficacy of Atezolizumab (MPDL3280A) in combination with carboplatin + paclitaxel or carboplatin + nab-paclitaxel.

  • IMpower 150

    Randomized, open-label study will evaluate the safety and efficacy of Atezolizumab (MPDL3280A) in combination with carboplatin and paclitaxel.

  • JAVELIN OVARIAN 100

    Study of avelumab in combination with and/or following platinum-based chemotherapy.

Page of 4, showing trials 1-10 of 34

Clincal Trials & Research Studies

Patient Stories

We’re writing new chapters in the lives of our patients, their families and our community daily. These are their stories:

Local Health News - In Your Inbox

Join over 45k of your friends & neighbors and get the latest news about community health programs and events when you sign-up for Adventist HealthCare & You Digital.

Subscribe Today!